2026-526764-21-00招募中1 期
A Phase 1 Trial to Evaluate the Safety, PK, and PD of AX-0811 in Healthy Participants
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 44
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Operations
Scientific
ProQR Therapeutics VIII B.V.
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A Phase I study to evaluate the safety and efficacy of L19IL2 in combination with ruxolitinib in patients with advanced solid tumors.Advanced solid tumors, specifically:
• metastatic clear cell renal carcinoma
• proficient mismatch repair / microsatellite stable (pMMR/MSS), BRAF-V600E-mutant negative colorectal carcinoma
• locally advanced or metastatic pancreatic adenocarcinoma2025-522243-17-00Philogen S.p.A.96
招募中
1 期
A phase 1b trial to study the safety and effect of ZP9830 in patients with plaque psoriasisPlaque Psoriasis2026-525220-15-00Zealand Pharma A/S32
招募中
1 期
Phase Ib Dose-Ranging Study of the Safety, PK, PD & Efficacy of the Activin Signaling Inhibitor HS235 vs placebo added to background therapy in PAH (SEASIDE)Pulmonary arterial hypertension2025-523010-89-0035Pharma Inc.2
招募中
不适用
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.Idiopathic Pulmonary Fibrosis (IPF)jRCT204126008718
尚未招募
1 期
A Study of SRSD384 in Overweight or Obese ParticipantsOverweight , ObesityNCT07557355Sirius Therapeutics Co., Ltd.78